Global newborn screening testing market
- MAR2978624
- 173 Pages
- September 2018
- Pharmaceuticals
Newborn screening tests cannot confirm or rule out diseases. They can only identify babies who may have a particular condition. This helps as follow up tests can be done which can give definitive results.
Market Dynamics
Due to increased awareness and improvement in technology the demand for newborn screening testing is increasing. Also due to increase in congenial heart defects the need for newborn screening is increasing. Government has also played a key factor in this matter due to increased funding. More and more physicians are also advising and pushing for newborn screening testing. However, growth is impeded due to lack of infrastructure, trained professional and socio-economic barriers.
Market Segmentation
The market is segmented on the basis of technology, product, test type and geography. Further sub divisions based on technology are tandem mass spectrometry, DNA based assay, enzyme, immune assay, electrophoresis, hearing screening technology, pulse oxymetry technology. Sub divisions of product are new-born disorder screening instruments, hearing screening devices, accessories, pulse oxymetry, regions and assay kits. On the basis of test type market has been divided into critical congenital heart disease test, hearing screening test and dry blood spot test.
Regional/Geographic Analysis
North America dominates the global newborn screening market due to low healthcare cost. Newborn screening market is said to increase in Asia in the next five years. Both India and China are growing markets for newborn screening testing due to a large pool of patients and increasing healthcare expenditure.
Key Players
Apollo Cradle, Life Cell, March of Dimes, Baby's First Test, Baby Genes are some of the key players in newborn screening testing. Other key players include AB Sciex LLC, Bio-Rad Laboratories, Agilent Technologies and Covidien PLC.
The report contains comprehensive analysis on:
--> Newborn screening testingMarket Segments
--> Newborn screening testingMarket Drivers, Restraints and Opportunities
--> Newborn screening testingSize & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Newborn screening testingMarket Current Trends
--> Competition &Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Feed Software Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
1.1. Market Definition
1.2. Market Taxonomy
2. Research Methodology
3. Assumptions and Acronyms
4. Executive Summary
5. Consumer Analysis
5.1. Consumer Profile (Demographic, Geographic, etc.)
5.2. Consumer Motivation
5.3. Procurement Process
5.4. Frequency of Buying
6. Historical Overview (Market Origins, Product Launch
Timeline, etc.)
7. Pricing Analysis
8. Market Dynamics
8.1. Macroeconomic Factors
8.2. Drivers
8.2.1. Supply Side
8.2.2. Demand Side
8.3. Restraints
8.4. Opportunities
9. R&D Status and Technology Overview
10. Global Newborn Screening Market Analysis, By Disease
Type
10.1.Introduction
10.2.Prominent Trends
10.3.Regulatory Guidelines
10.4.Market Size and Analysis, By Disease Type
10.4.1. Phenylketonuria (PKU)
10.4.2. Cystic fibrosis
10.4.3. Sickle Cell Disease
10.4.4. Congenital Heart Diseases
10.4.5. Hearing Loss
10.4.6. Others
10.5.Market Share Analysis and YoY Growth Rates, By
Disease Type
11. Global Newborn Screening Market Analysis, By Product
Type
11.1. Introduction
11.2.Prominent Trends
11.3.Regulatory Guidelines
11.4. Market Size and Analysis, By Product Type
11.4.1. Service
11.4.1.1. Hospitals & Clinics
11.4.1.2. Specialist
11.4.1.2.1. General Diagnostic Centers
11.4.1.2.2. Specialist Clinics and Screening
Centers
11.4.2. Instruments/Devices
11.4.2.1. Primary Devices and Instruments
11.4.2.2. Accessories
11.4.2.3. Testing Kits
11.5. Market Share Analysis and YoY Growth Rates, By
Product Type
12. Global Newborn Screening Market Analysis, By
Technology
12.1. Introduction
12.2.Prominent Trends
12.3.Regulatory Guidelines
12.4. Market Size and Analysis, By Technology
12.4.1.1. Hearing
12.4.1.1.1. Otoacoustic Emissions (OAE) Test
12.4.1.1.2. Auditory Brain Stem Response
(ABR) Test
12.4.1.2. Heart Conditions
12.4.1.2.1. Pulse Oximetry
12.4.1.2.2. Others
12.4.1.3. Enzyme Assays
12.4.1.4. DNA and Molecular-based Testing
12.4.1.5. Spectrometry
12.4.1.6. Others
12.5. Market Share Analysis and YoY Growth Rates, By
Technology
13. Global Newborn Screening Market Analysis, By Region
13.1.Introduction
13.2.Prominent Trends
13.3.Regulatory Guidelines
13.4.Market Size and Analysis, By Region
13.4.1. North America
13.4.2. Latin America
13.4.3. Europe
13.4.4. Asia Pacific
13.4.5. Middle East & Africa (MEA)
13.5.Market Share Analysis and YoY Growth Rates, By
Region
14. North America Newborn Screening Market Analysis
14.1.Introduction
14.2.Prominent Trends
14.3.North America Newborn Screening Market Analysis, by
Country
14.3.1. U.S.
14.3.2. Canada
14.4.North America Newborn Screening Market Size and
Analysis, By Disease Type
14.4.1. Phenylketonuria (PKU)
14.4.2. Cystic fibrosis
14.4.3. Sickle Cell Disease
14.4.4. Congenital Heart Diseases
14.4.5. Hearing Loss
14.4.6. Others
14.5.North America Newborn Screening Market Analysis, By
Product Type
14.5.1.1. Hospitals & Clinics
14.5.1.2. Specialist
14.5.1.2.1. General Diagnostic Centers
14.5.1.2.2. Specialist Clinics and Screening
Centers
14.5.2. Instruments/Devices
14.5.2.1. Primary Devices and Instruments
14.5.2.2. Accessories
14.5.2.3. Testing Kits
14.6. North America Newborn Screening Market Size and
Analysis, By Technology
14.6.1.1. Hearing
14.6.1.1.1. Otoacoustic Emissions (OAE) Test
14.6.1.1.2. Auditory Brain Stem Response
(ABR) Test
14.6.1.2. Heart Conditions
14.6.1.2.1. Pulse Oximetry
14.6.1.2.2. Others
14.6.1.3. Enzyme Assays
14.6.1.4. DNA and Molecular-based Testing
14.6.1.5. Spectrometry
14.6.1.6. Others
14.7.Market Share Analysis and YoY Growth Rates
14.7.1. By Country
14.7.2. By Disease Type
14.7.3. By Technology
14.7.4. By Product Type
15. Latin America Newborn Screening Market Analysis
15.1.Introduction
15.2.Prominent Trends
15.3.Latin America Newborn Screening Market Analysis, by
Country
15.3.1. Mexico
15.3.2. Brazil
15.3.3. Others
15.4.Latin America Newborn Screening Market Market Size
and Analysis, By Disease Type
15.4.1. Phenylketonuria (PKU)
15.4.2. Cystic fibrosis
15.4.3. Sickle Cell Disease
15.4.4. Congenital Heart Diseases
15.4.5. Hearing Loss
15.4.6. Others
15.5.Latin America Newborn Screening Market Analysis, By
Product Type
15.5.1. Service
15.5.1.1. Hospitals & Clinics
15.5.1.2. Specialist
15.5.1.2.1. General Diagnostic Centers
15.5.1.2.2. Specialist Clinics and Screening
Centers
15.5.2. Instruments/Devices
15.5.2.1. Primary Devices and Instruments
15.5.2.2. Accessories
15.5.2.3. Testing Kits
15.6. Latin America Newborn Screening Market Size and
Analysis, By Technology
15.6.1.1. Hearing
15.6.1.1.1. Otoacoustic Emissions (OAE) Test
15.6.1.1.2. Auditory Brain Stem Response
(ABR) Test
15.6.1.2. Heart Conditions
15.6.1.2.1. Pulse Oximetry
15.6.1.2.2. Others
15.6.1.3. Enzyme Assays
15.6.1.4. DNA and Molecular-based Testing
15.6.1.5. Spectrometry
15.6.1.6. Others
15.7.Market Share Analysis and YoY Growth Rates
15.7.1. By Country
15.7.2. By Disease Type
15.7.3. By Technology
15.7.4. By Product Type
16. Europe Newborn Screening Market Analysis
16.1.Introduction
16.2.Prominent Trends
16.3.Europe Newborn Screening Market Analysis, by
Country
16.3.1. Germany
16.3.2. U.K.
16.3.3. Spain
16.3.4. France
16.3.5. Italy
16.3.6. Russia
16.3.7. Others
16.4.Europe Newborn Screening Market Size and Analysis,
By Disease Type
16.4.1. Phenylketonuria (PKU)
16.4.2. Cystic fibrosis
16.4.3. Sickle Cell Disease
16.4.4. Congenital Heart Diseases
16.4.5. Hearing Loss
16.4.6. Others
16.5.Europe Newborn Screening Market Analysis, By
Product Type
16.5.1. Service
16.5.1.1. Hospitals & Clinics
16.5.1.2. Specialist
16.5.1.2.1. General Diagnostic Centers
16.5.1.2.2. Specialist Clinics and Screening
Centers
16.5.2. Instruments/Devices
16.5.2.1. Primary Devices and Instruments
16.5.2.2. Accessories
16.5.2.3. Testing Kits
16.6. Europe Newborn Screening Market Size and Analysis,
By Technology
16.6.1.1. Hearing
16.6.1.1.1. Otoacoustic Emissions (OAE) Test
16.6.1.1.2. Auditory Brain Stem Response
(ABR) Test
16.6.1.2. Heart Conditions
16.6.1.2.1. Pulse Oximetry
16.6.1.2.2. Others
16.6.1.3. Enzyme Assays
16.6.1.4. DNA and Molecular-based Testing
16.6.1.5. Spectrometry
16.6.1.6. Others
16.7.Market Share Analysis and YoY Growth Rates
16.7.1. By Country
16.7.2. By Disease Type
16.7.3. By Technology
16.7.4. By Product Type
17. Asia Pacific Newborn Screening Market Analysis
17.1.Introduction
17.2.Prominent Trends
17.3.Asia Pacific Newborn Screening Market Analysis, by
Country
17.3.1. India
17.3.2. China
17.3.3. Australia & New Zealand
17.3.4. Japan
17.3.5. Others
17.4.Asia Pacific Newborn Screening Market Market Size and
Analysis, By Disease Type
17.4.1. Phenylketonuria (PKU)
17.4.2. Cystic fibrosis
17.4.3. Sickle Cell Disease
17.4.4. Congenital Heart Diseases
17.4.5. Hearing Loss
17.4.6. Others
17.5.Asia Pacific Newborn Screening Market Analysis, By
Product Type
17.5.1. Service
17.5.1.1. Hospitals & Clinics
17.5.1.2. Specialist
17.5.1.2.1. General Diagnostic Centers
17.5.1.2.2. Specialist Clinics and Screening
Centers
17.5.2. Instruments/Devices
17.5.2.1. Primary Devices and Instruments
17.5.2.2. Accessories
17.5.2.3. Testing Kits
17.6. Asia Pacific Newborn Screening Market Size and
Analysis, By Technology
17.6.1.1. Hearing
17.6.1.1.1. Otoacoustic Emissions (OAE) Test
17.6.1.1.2. Auditory Brain Stem Response
(ABR) Test
17.6.1.2. Heart Conditions
17.6.1.2.1. Pulse Oximetry
17.6.1.2.2. Others
17.6.1.3. Enzyme Assays
17.6.1.4. DNA and Molecular-based Testing
17.6.1.5. Spectrometry
17.6.1.6. Others
17.7.Market Share Analysis and YoY Growth Rates
17.7.1. By Country
17.7.2. By Disease Type
17.7.3. By Technology
17.7.4. By Product Type
18. Middle East and Africa (MEA) Newborn Screening Market
Analysis
18.1.Introduction
18.2.Prominent Trends
18.3.Middle East and Africa Newborn Screening Market
Analysis, by Country
18.3.1. GCC countries
18.3.2. South Africa
18.3.3. North Africa
18.3.4. Rest of Middle East and Africa
18.4.Middle East and Africa Newborn Screening Market Size
and Analysis, By Disease Type
18.4.1. Phenylketonuria (PKU)
18.4.2. Cystic fibrosis
18.4.3. Sickle Cell Disease
18.4.4. Congenital Heart Diseases
18.4.5. Hearing Loss
18.4.6. Others
18.5.Middle East and Africa Newborn Screening Market
Analysis, By Product Type
18.5.1. Service
18.5.1.1. Hospitals & Clinics
18.5.1.2. Specialist
18.5.1.2.1. General Diagnostic Centers
18.5.1.2.2. Specialist Clinics and Screening
Centers
18.5.2. Instruments/Devices
18.5.2.1. Primary Devices and Instruments
18.5.2.2. Accessories
18.5.2.3. Testing Kits
18.6. Middle East and Africa Newborn Screening Market Size
and Analysis, By Technology
18.6.1.1. Hearing
18.6.1.1.1. Otoacoustic Emissions (OAE) Test
18.6.1.1.2. Auditory Brain Stem Response
(ABR) Test
18.6.1.2. Heart Conditions
18.6.1.2.1. Pulse Oximetry
18.6.1.2.2. Others
18.6.1.3. Enzyme Assays
18.6.1.4. DNA and Molecular-based Testing
18.6.1.5. Spectrometry
18.6.1.6. Others
18.7.Market Share Analysis and YoY Growth Rates
18.7.1. By Country
18.7.2. By Disease Type
18.7.3. By Technology
18.7.4. By Product Type
19. Industry Structure
19.1. Porters Five Forces Analysis
19.1.1. Bargaining Power of Suppliers
19.1.2. Bargaining Power of Buyers
19.1.3. Threat of New Entrants
19.1.4. Threat of Substitute Products and Services
19.1.5. Internal Rivalry
19.2.Supply Chain Analysis and Profitability Margins
19.3.Market Share Analysis
19.4. Strategic Analysis
19.4.1. Competitive Strategies
19.4.2. Mergers & Acquisitions Activity
19.4.3. Co-operative Agreements
19.5. Critical Success Factor (CSF) Analysis (Technology &
Manufacturing, Design & Features, Brand Reputation,
Distribution Network, Marketing)
19.6.Company Profiles (Overview, Product/Service Details,
Geographic Scope, Financials, Strategic Intent & Approach,
Core Competencies & Competitive Advantage and Key
developments)
19.6.1. AB Sciex
19.6.2. Agilent Technologies, Inc.
19.6.3. Bio-Rad Laboratories, Inc.
19.6.4. Masimo Corporation
19.6.5. Medtronic, Inc.
19.6.6. Natus Medical Incorporated
19.6.7. PerkinElmer, Inc.
19.6.8. Trivitron Healthcare
19.6.9. ZenTech S.A
19.6.10. Waters Corporation
19.6.11. Covidien PLC
19.6.12. GE Healthcare
20. Prognosis for the Future
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
